Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Kyowa Hakko Kirin Co Ltd    4151   JP3256000005

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2017 347 412 M
EBIT 2017 -
Net income 2017 20 730 M
Finance 2017 47 522 M
Yield 2017 1,19%
Sales 2018 357 592 M
EBIT 2018 -
Net income 2018 24 349 M
Finance 2018 61 972 M
Yield 2018 1,25%
P/E ratio 2017 56,22
P/E ratio 2018 47,78
EV / Sales2017 3,35x
EV / Sales2018 3,22x
Capitalization 1 211 768 M
More Financials
Company
Kyowa Hakko Kirin Co., Ltd. is a holding company which engages in the manufacture and sale of medical and pharmaceutical products.It operates through the Pharmaceuticals and Bio-Chemicals segments.The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro... 
More about the company
Surperformance© ratings of Kyowa Hakko Kirin Co Ltd
Trading Rating : Investor Rating :
More Ratings
Latest news on KYOWA HAKKO KIRIN CO LTD
06/23 PARTNERSHIP AGREEMENT FOR A GEL FORM : Treatment for Psoriasis Vulgaris
06/22 PARTNERSHIP AGREEMENT FOR A GEL FORM : Treatment for Psoriasis Vulgaris(130KB)
06/09 KYOWA HAKKO KIRIN : Pharmaceutical firm boss applauds expansion work
05/25 KYOWA HAKKO KIRIN : Patent Issued for Method of Purifying Protein (USPTO 9650411..
05/22 KYOWA HAKKO KIRIN : FUJIFILM KYOWA KIRIN BIOLOGICS Announces Marketing Authorisa..
05/05 KYOWA HAKKO KIRIN : Kirin, Inc. and Dream Foundation Partner to Serve Adults at ..
04/28 KYOWA HAKKO KIRIN : Submits Application for Approval of Evocalcet (KHK7580) for ..
04/27 KYOWA HAKKO KIRIN : Researchers Submit Patent Application, "RNAi PHARMACEUTICAL ..
04/27 KYOWA HAKKO KIRIN : Submits Application for Approval of Evocalcet (KHK7580) for ..
04/20 KYOWA HAKKO KIRIN : Ultragenyx, Kyowa Hakko Kirin plan a date with the FDA after..
More news
Sector news : Specialty & Advanced Pharmaceuticals
06/26DJASTRAZENECA : ADRs End Mostly Higher
06/26 VALEANT PHARMACEUTICALS INTL : Hedge fund Paulson & Co discloses 6.3 percent sta..
06/26DJHow Third Point's Nestlé Move Could Affect L'Oréal
06/23DJSAMSUNG ELECTRONICS : Makes Play for Drug Market With Version of Humira -- Updat..
06/23DJSAMSUNG ELECTRONICS : Makes Big Play in Drug Market With Cheaper Version of Bloc..
More sector news : Specialty & Advanced Pharmaceuticals
Latest Tweets
04/19Ultragenyx, Kyowa Hakko Kirin And Announce Positive 24-Week Data From Adult P.. 
04/07BRIEF-Kyowa Hakko Kirin Co Ltd's phase 3 study of mogamulizumab a met its pr.. 
01/31Kyowa Hakko Kirin : Notice of Recording of Extraordinary Losses in Non-consol.. 
2016Kyowa Hakko Kirin hit with a new PhIII setback on an old Parkinson’s drug  
2016Kyowa Hakko Kirin : Application seeking Approval for Additional formulation o.. 
More tweets
Qtime:11
News from SeekingAlpha
04/10 3 THINGS IN BIOTECH YOU SHOULD LEARN : Volume 4
01/05 Ultragenyx and Kyowa Kirin announce MAA for KRN23 filed and accepted for revi..
2016 ArQule Is Undervalued Going Into Catalyst Events
Advertisement
Chart KYOWA HAKKO KIRIN CO LTD
Duration : Period :
Kyowa Hakko Kirin Co Ltd Technical Analysis Chart | 4151 | JP3256000005 | 4-Traders
Full-screen chart
Technical analysis trends KYOWA HAKKO KIRIN...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 2 242  JPY
Spread / Average Target 6,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Nobuo Hanai President & Representative Director
Yoichi Sato Director, Managing Executive Officer, GM-R&D
Kazuyoshi Tachibana Director & Managing Executive Officer
Toshifumi Mikayama Director & Managing Executive Officer
Koichiro Nishikawa Independent Outside Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
KYOWA HAKKO KIRIN CO L..29.91%10 787
ABBVIE16.16%115 610
MERCK KGAA12.10%16 065
JAZZ PHARMACEUTICALS P..45.65%9 542
CONVATEC GROUP43.05%8 300
ZHANGZHOU PIENTZEHUANG..31.71%5 324
More Results